Weizmann in the Media Archives - Weizmann Canada
NEWS & MEDIA
Weizmann News
Weizmann in the Media
Sustainability and food security challenges are reaching a critical point. Communities around the world are feeling the effects of a crisis that is driven by factors like climate change and resource depletion. At the same time, a tremendous global effort in pursuit of viable solutions has been gathering momentum, driven by the passion of scientists and the philanthropic community supporting them.
Science Stories | Weizmann in the Media
Leveraging research excellence to develop solutions to urgent global challenges
Press Release | Weizmann in the Media
On May 16 Weizmann Canada’s Montreal Chapter hosted a gala event dedicated to celebrating the philanthropic partners who support the work of researchers at the Weizmann Institute of Science. The event, called “LIMITLESS”, hosted more than 300 philanthropic leaders and members of the Montreal community.
To the Moon
Weizmann in the Media | Science Stories
Israel’s first unmanned interplanetary spacecraft will launch in the beginning of 2019 aboard a SpaceX Falcon 9 rocket from the Kennedy Space Station in Cape Canaveral, Florida. If it lands on the Moon two months later, as hoped, Israel will join an exclusive club of countries—U.S., Russia, and China—that have sent spacecraft to the surface of Earth’s nearest planetary neighbor. The spacecraft was recently named Beresheet, the Hebrew word for ‘beginning’ and Genesis, the first book of the Old Testament.
Yaron Lipman
Weizmann in the Media | Science Stories
Yaron Lipman is a professor in the computer science and applied mathematics department at the Weizmann Institute in Rehovot, Israel. Lipman heads a team doing cutting-edge research into the development of new technologies that can allow computers to capture images, analyze and manipulate them, and construct fragments into a coherent image. Lipman spoke to Weizmann supporters in Toronto, Montreal and Calgary recently.
Weizmann in the Media
Mismatched bone marrow transplants now save the lives of thousands of patients with leukemia and other blood malignancies, but these transplants can be risky.